Pregled bibliografske jedinice broj: 1031672
Incidence of the 35delG/GJB2 mutation in low-risk newborns
Incidence of the 35delG/GJB2 mutation in low-risk newborns // The Journal of Maternal-Fetal & Neonatal Medicine, 21 (2008), 7; 463-468 doi:10.1080/14767050802123975 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1031672 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Incidence of the 35delG/GJB2 mutation in low-risk newborns
Autori
Zaputovic, Sanja ; Stanojevic, Milan ; Medica, Igor ; Peterlin, Borut ; Petrovic, Oleg
Izvornik
The Journal of Maternal-Fetal & Neonatal Medicine (1476-7058) 21
(2008), 7;
463-468
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
neonates ; universal hearing screening ; otoacoustic emission ; auditory brainstem response ; genetic deafness ; 35delG/GJB2 mutation
Sažetak
Objective. To investigate, in a prospective study, the incidence of homozygotes and heterozygotes of the 35delG/GJB2 mutation for connexin 26 in the low-risk population of newborns undergoing two-stage universal neonatal hearing screening (UNHS). Patients and methods. The study population consisted of 1048 neonates born at the Department of Obstetrics and Gynecology, Rijeka University Hospital, Croatia, in the period between March 1, 2005 and June 30, 2005. The neonates underwent a two-stage UNHS program that included evoked otoacoustic emission (E-OAE) in all infants and automated auditory brainstem response (A-ABR) in those who did not pass the E-OAE. The 35delG/GJB2 mutation was determined in the umbilical cord blood of all examinees. Results. Fifteen out of 1048 infants (14.3 per 1000) did not pass the E-OAE, of whom three (2.86 per 1000) did not pass the A-ABR (two unilateral, one bilateral). The 35delG/GJB2 mutation was found in 13 out of 1033 infants who did pass the E-OAE and in one who did not pass the E- OAE. Thirteen out of 14 infants were heterozygotes (12.4 per 1000) and one infant was homozygote (0.95 per 1000) for the 35delG/GJB2 mutation. The homozygous infant had a bilateral pathological result on E-OAE and A- ABR, while 13 infants who were homozygotes passed the E-OAE. Conclusion. In all neonates, regardless of hearing impairment, genetic testing for the 35delG/GJB2 mutation is desirable in southern Croatia. The incidence of affected homozygous and healthy heterozygous transmitters of the 35delG/GJB2 mutation was in concordance with findings in southern European countries.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Rijeka,
Klinički bolnički centar Rijeka
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE